Contineum Therapeutics, Inc. Class A Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
JOHNSON & JOHNSON | 05/07/2025 | 1.98 M | $13.81 M | 0.00% | 7.65% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.72 M | $12.01 M | 0.00% | 6.65% |
FRANKLIN RESOURCES INC | 05/13/2025 | 1.58 M | $11.00 M | 9.04% | 6.09% |
PERCEPTIVE ADVISORS LLC | 05/15/2025 | 1.44 M | $10.06 M | 0.00% | 5.57% |
FMR LLC | 05/12/2025 | 810.32 K | $5.66 M | 17.12% | 3.13% |
VANGUARD GROUP INC | 05/09/2025 | 803.43 K | $5.61 M | -0.70% | 3.11% |
SECTORAL ASSET MANAGEMENT INC | 05/15/2025 | 800.79 K | $5.59 M | 0.00% | 3.10% |
HHLR ADVISORS, LTD. | 05/15/2025 | 669.34 K | $4.67 M | 0.00% | 2.59% |
BLACKROCK, INC. | 05/02/2025 | 616.62 K | $4.30 M | 2.16% | 2.38% |
SAMSARA BIOCAPITAL, LLC | 05/15/2025 | 588.82 K | $4.11 M | 0.00% | 2.28% |
SATURN V CAPITAL MANAGEMENT LLC | 05/15/2025 | 560.98 K | $3.92 M | -2.10% | 2.17% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 312.50 K | $2.18 M | 0.00% | 1.21% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 193.05 K | $1.35 M | 2.46% | 0.75% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 168.77 K | $1.18 M | 105.23% | 0.65% |
CASDIN CAPITAL, LLC | 05/15/2025 | 148.33 K | $1.04 M | -50.00% | 0.57% |
SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 142.20 K | $992.56 K | 12.86% | 0.55% |
SQUAREPOINT OPS LLC | 05/15/2025 | 131.03 K | $914.57 K | -39.69% | 0.51% |
STATE STREET CORP | 05/15/2025 | 126.86 K | $885.51 K | 1.70% | 0.49% |
NORTHERN TRUST CORP | 05/13/2025 | 83.63 K | $583.71 K | -6.31% | 0.32% |
MORGAN STANLEY | 05/15/2025 | 57.16 K | $398.96 K | 115.23% | 0.22% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 51.20 K | $357.39 K | -7.46% | 0.20% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 42.50 K | $300.47 K | -37.79% | 0.16% |
MARSHALL WACE, LLP | 05/15/2025 | 31.08 K | $216.97 K | 186.86% | 0.12% |
STRATEGIES WEALTH ADVISORS, LLC | 05/14/2025 | 25.00 K | $174.50 K | 0.00% | 0.10% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 19.90 K | $138.90 K | 6.20% | 0.08% |
DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 05/16/2025 | 16.84 K | $118.00 K | 100.00% | 0.07% |
DEUTSCHE BANK AG\ | 05/09/2025 | 16.08 K | $112.23 K | 0.00% | 0.06% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 14.22 K | $99.26 K | -46.06% | 0.06% |
05/12/2025 | 13.31 K | $92.88 K | 100.00% | 0.05% | |
UBS GROUP AG | 05/13/2025 | 13.29 K | $92.79 K | -46.57% | 0.05% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 13.26 K | $92.53 K | 100.00% | 0.05% |
BARCLAYS PLC | 05/15/2025 | 11.08 K | $77.00 K | -31.95% | 0.04% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 10.88 K | $75.92 K | 1.13% | 0.04% |
RHUMBLINE ADVISERS | 05/29/2025 | 7.57 K | $52.85 K | -8.02% | 0.03% |
CITIGROUP INC | 05/12/2025 | 7.39 K | $51.56 K | -10.75% | 0.03% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 6.09 K | $42.54 K | 3.99% | 0.02% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 5.77 K | $40.27 K | -36.83% | 0.02% |
JPMORGAN CHASE & CO | 05/12/2025 | 5.17 K | $36.07 K | -81.82% | 0.02% |
COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 5.14 K | $35.87 K | -1.46% | 0.02% |
STRS OHIO | 05/28/2025 | 3.90 K | $27.22 K | 0.00% | 0.02% |
LEGAL & GENERAL GROUP PLC | 05/15/2025 | 3.63 K | $25.34 K | 0.00% | 0.01% |
05/09/2025 | 1.40 K | $9.74 K | 0.00% | 0.01% | |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 1.36 K | $9.48 K | 44.01% | 0.01% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 05/15/2025 | 783 | $5.47 K | 0.00% | 0.00% |
AMERITAS INVESTMENT PARTNERS, INC. | 05/12/2025 | 680 | $4.75 K | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 628 | $4.38 K | -52.32% | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 600 | $4.00 K | 0.00% | 0.00% |
CWM, LLC | 05/01/2025 | 415 | $3.00 K | 100.00% | 0.00% |
AMALGAMATED BANK | 04/25/2025 | 362 | $3.00 K | 50.83% | 0.00% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 318 | $2.22 K | 100.00% | 0.00% |
Contineum Therapeutics, Inc. Class A Common Stock institutional Ownership - FAQ's
During the previous two years, 65 institutional investors and hedge funds held shares of Contineum Therapeutics, Inc. Class A Common Stock. The most heavily invested institutionals were:
JOHNSON & JOHNSON: 1.98 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 1.72 M
FRANKLIN RESOURCES INC: 1.58 M
PERCEPTIVE ADVISORS LLC: 1.44 M
FMR LLC: 810,317
VANGUARD GROUP INC: 803,428
52.44% of Contineum Therapeutics, Inc. Class A Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 13.83 M shares in the last 24 months. This purchase volume represents approximately $53.64 M in transactions.